Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hatty

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Anti-Cancer Drugs|June 13, 1998
Gemcitabine--a safety reviewM S Aapro, C Martin, S Hatty
Postgraduate Medical Journal|September 1, 1983
Exercise-induced urticaria and angio-oedema with relief from cromoglycate insufflationS Hatty, G J Mufti, T J Hamblin
Acta Haematologica|January 1, 1985
Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosisS Hatty, G J Mufti, T J Hamblin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescueC Sessa, J de Jong, M D'Incalci, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancerM E O'Brien, J Hardy, S Tan, et al.
Anti-Cancer Drugs|August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancerA Kamthan, J H Scarffe, J Walling, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|June 13, 1998
Gemcitabine--a safety reviewM S Aapro, C Martin, S Hatty
Postgraduate Medical Journal|September 1, 1983
Exercise-induced urticaria and angio-oedema with relief from cromoglycate insufflationS Hatty, G J Mufti, T J Hamblin
Acta Haematologica|January 1, 1985
Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosisS Hatty, G J Mufti, T J Hamblin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescueC Sessa, J de Jong, M D'Incalci, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancerM E O'Brien, J Hardy, S Tan, et al.
Anti-Cancer Drugs|August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancerA Kamthan, J H Scarffe, J Walling, et al.
Pageof 1